http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022135578-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d42d445a771ee30222eddbe900c23c70 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-0271 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C249-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B41-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C41-56 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10 |
filingDate | 2021-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_054e6b39ad977cafd84758244cf1bcb3 |
publicationDate | 2022-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2022135578-A1 |
titleOfInvention | Preparation and Application of A 5-bromoquinazoline Derivative |
abstract | A 5-bromoquinazoline derivative (I), structural formula thereof is as follows: n n n n n n n n n n the synthesis method thereof comprises weighing 1.18 g of 5-bromoisatin, 2.5503 g of ammonium formate and 100 ml of absolute methanol in a 250 mL round-bottom flask, heating, stirring and refluxing for 48 h, stopping reaction, rotating to obtain 1.6033 g of filter residue crude product, carrying out column chromatography separation by using dichloromethane and absolute methanol according to a volume ratio of 1:1, and obtaining a target crystal compound I; the application of the 5-bromoquinazoline derivative compound crystal (I), as a catalyst has a good catalytic effect in nitrile silicification reaction of benzaldehyde and auto-polymerization reaction of benzophenone hydrazone, the conversion rates thereof respectively reach 39% and 76%, and the crystal (I) can be used as an anti-cancer reagent which has certain anti-cancer activity of breast cancer, liver cancer and lung cancer. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115304536-A |
priorityDate | 2020-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 48.